Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods

Alfred B Tiono, David T Kangoye, Andrea M Rehman, Désiré G Kargougou, Youssouf Kaboré, Amidou Diarra, Esperance Ouedraogo, Issa Nébié, Alphonse Ouédraogo, Brenda Okech, Paul Milligan, Sodiomon B Sirima, Alfred B Tiono, David T Kangoye, Andrea M Rehman, Désiré G Kargougou, Youssouf Kaboré, Amidou Diarra, Esperance Ouedraogo, Issa Nébié, Alphonse Ouédraogo, Brenda Okech, Paul Milligan, Sodiomon B Sirima

Abstract

Background: The aim of this study was to determine the incidence and seasonal pattern of malaria in children in South-West Burkina Faso, and to compare, in a randomized trial, characteristics of cases detected by active and passive surveillance. This study also enabled the planning of a malaria vaccine trial.

Methods: Households with young children, located within 5 kilometers of a health facility, were randomized to one of two malaria surveillance methods. In the first group, children were monitored actively. Each child was visited twice weekly; tympanic temperature was measured, and if the child had a fever or history of fever, a malaria rapid diagnostic test was performed and a blood smear collected. In the second group, children were monitored passively. The child's parent or caregiver was asked to bring the child to the nearest clinic if he was unwell. Follow up lasted 13 months from September 2009.

Results: Incidence of malaria (Fever with parasitaemia ≥5,000/µL) was 1.18 episodes/child/year in the active cohort and 0.89 in the passive cohort (rate ratio 1.32, 95% CI 1.13-1.54). Malaria cases in the passive cohort were more likely to have high grade fever; but parasite densities were similar in the two groups. Incidence was highly seasonal; when a specific case definition was used, about 60% of cases occurred within the 4 months June-September.

Conclusion: Passive case detection required at least a 30%-40% increase in the sample size for vaccine trials, compared to active detection, to achieve the same power. However we did not find any evidence that parasite densities were higher with passive than with active detection. The incidence of malaria is highly seasonal and meets the WHO criteria for Seasonal Malaria Chemoprevention (SMC). At least half of the malaria cases in these children could potentially be prevented if SMC was effectively deployed.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Map of the study area,…
Figure 1. Map of the study area, Banfora district, Burkina Faso Households of study participants are identified as “white circle” when assigned to active case detection and “gray circle” when assigned to passive case detection.
Figure 2. Study profile.
Figure 2. Study profile.
Figure 3. Nelson-Aalen cumulative hazard, mean number…
Figure 3. Nelson-Aalen cumulative hazard, mean number of children with a measured fever and a parasite density of 5,000/µL or more, by surveillance method.
Figure 4. Nelson-Aalen cumulative hazard, mean number…
Figure 4. Nelson-Aalen cumulative hazard, mean number of children with a measured fever or history of fever in the last 24 hours and a positive RDT, by surveillance method.
Figure 5. Arithmetic mean tympanic temperature (°C)…
Figure 5. Arithmetic mean tympanic temperature (°C) among children with parasite positive malaria cases by calendar month.
Figure 6. Arithmetic mean parasite density among…
Figure 6. Arithmetic mean parasite density among parasite positive malaria cases by calendar month.
Figure 7. Malaria case definition using objective…
Figure 7. Malaria case definition using objective fever (Temperature≥38.0): Sensitivity and specificity of alternatives parasite threshold.
Figure 8. Malaria case definition using objective…
Figure 8. Malaria case definition using objective fever (Temperature≥38.0)/History of fever: Sensitivity and specificity of alternatives parasite threshold.

References

    1. De Allegri M, Louis VR, Tiendrebeogo J, Souares A, Ye M, et al. (2013) Moving towards universal coverage with malaria control interventions: achievements and challenges in rural Burkina Faso. Int J Health Plann Manage 28: 102–121.
    1. Badolo A, Traore A, Jones CM, Sanou A, Flood L, et al. (2012) Three years of insecticide resistance monitoring in Anopheles gambiae in Burkina Faso: resistance on the rise? Malar J 11: 232.
    1. Dabire RK, Namountougou M, Sawadogo SP, Yaro LB, Toe HK, et al. (2012) Population dynamics of Anopheles gambiae s.l. in Bobo-Dioulasso city: bionomics, infection rate and susceptibility to insecticides. Parasit Vectors 5: 127.
    1. Kwiatkowska RM, Platt N, Poupardin R, Irving H, Dabire RK, et al. (2013) Dissecting the mechanisms responsible for the multiple insecticide resistance phenotype in Anopheles gambiae s.s., M form, from Vallee du Kou, Burkina Faso. Gene 519: 98–106.
    1. Diarra A, Nebie I, Tiono A, Sanon S, Soulama I, et al. (2012) Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso. Parasit Vectors 5: 103.
    1. WHO (2012) World Malaria Report 2012. Available: . Accessed 2013 July 1.
    1. Konate AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, et al. (2011) Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS One 6: e23391.
    1. Ouedraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, et al. (2013) Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso. PLoS One 8: e50036.
    1. Moorthy VS, Reed Z, Smith PG (2009) Committee WHOMVA (2009) MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials–scientific, regulatory and public health perspectives. Vaccine 27: 624–628.
    1. Snow RW, Menon A, Greenwood BM (1989) Measuring morbidity from malaria. Ann Trop Med Parasitol 83: 321–323.
    1. Olotu A, Fegan G, Williams TN, Sasi P, Ogada E, et al. (2010) Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya. PLoS One 5: e15569.
    1. (DGISS): MdlS (2009) Annuaire Statistique 2008 du Burkina; Juin 2009.
    1. WHO (2012) WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Available: . Accessed 2013 July 1.
    1. Belard S, Issifou S, Hounkpatin AB, Schaumburg F, Ngoa UA, et al. (2011) A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children. PLoS One 6: e22525.
    1. Esen M, Kremsner PG, Schleucher R, Gassler M, Imoukhuede EB, et al. (2009) Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate. Vaccine 27: 6862–6868.
    1. Mordmuller B, Szywon K, Greutelaers B, Esen M, Mewono L, et al. (2010) Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon. Vaccine 28: 6698–6703.
    1. Olotu A, Fegan G, Wambua J, Nyangweso G, Ogada E, et al. (2012) Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One 7: e32929.
    1. Dicko A, Mantel C, Kouriba B, Sagara I, Thera MA, et al. (2005) Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali. Trop Med Int Health 10: 550–556.
    1. Rogers WO, Atuguba F, Oduro AR, Hodgson A, Koram KA (2006) Clinical case definitions and malaria vaccine efficacy. J Infect Dis 193: 467–473.

Source: PubMed

3
구독하다